BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4370454)

  • 21. Blockade of adrenergic potentiating effect of angiotensin by 1-Sar-8-Ala-angiotensin II.
    Zimmerman BG
    J Pharmacol Exp Ther; 1973 Jun; 185(3):486-92. PubMed ID: 4351403
    [No Abstract]   [Full Text] [Related]  

  • 22. [NO-synthase inhibition induces a resistant pressor reaction during the 10-minute intravenous infusion of angiotensin-2 to narcotized rats].
    Shebeko VI; Rodionov IuIa
    Biull Eksp Biol Med; 1993 Nov; 116(11):479-80. PubMed ID: 7508766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Angiotensin blockade and hypertension].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2396-7. PubMed ID: 4374772
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methylprednisolone sensitizes the rat to hypotensive effects of angiotensin II].
    Deheneffe J
    C R Seances Soc Biol Fil; 1974; 168(2-3):383-6. PubMed ID: 4376723
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of the pressor response to angiotensin and norepinephrine in the rat, induced by a renal peptide.
    Fasciolo JC; Risler NR
    Acta Physiol Lat Am; 1973; 23(6):521-2. PubMed ID: 4369126
    [No Abstract]   [Full Text] [Related]  

  • 27. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
    Hollenberg NK; Williams GH; Burger B; Ishikawa I; Adams DF
    J Clin Invest; 1976 Jan; 57(1):39-46. PubMed ID: 1245602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular permeability factor: dissociation from the angiotensin II induced pressor and drinking responses.
    Vaughan ED; Gavras H; Laragh JH; Koss MN
    Nature; 1973 Mar; 242(5396):334-5. PubMed ID: 4349236
    [No Abstract]   [Full Text] [Related]  

  • 29. [The cholinergic modulation of the pressor reaction to angiotensin].
    Fedorov VI
    Fiziol Zh SSSR Im I M Sechenova; 1991 Jul; 77(7):57-62. PubMed ID: 1668159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J; Regoli D
    Rev Can Biol; 1972 Dec; 31(4):241-51. PubMed ID: 4350595
    [No Abstract]   [Full Text] [Related]  

  • 31. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
    Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
    J Hypertens Suppl; 1986 Dec; 4(6):S408-11. PubMed ID: 3475426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues.
    Stachowiak K; Khosla MC; Plucinska K; Khairallah PA; Bumpus FM
    J Med Chem; 1979 Sep; 22(9):1128-30. PubMed ID: 490561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of an angiotensin II analogue on pressor and adrenal receptors in the rabbit.
    Steele JM; Lowenstein J
    Circ Res; 1974 Oct; 35(4):592-600. PubMed ID: 4369923
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of angiotensin-II intravenous infusion on plasma renin activity and prostaglandins A, E, and F levels in the uterine vein of the pregnant monkey.
    Franklin GO; Dowd AJ; Caldwell BV; Speroff L
    Prostaglandins; 1974 May; 6(4):271-80. PubMed ID: 4369285
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-lasting inhibition of angiotensin response in rats by depot administration of octanoyl-[Leu8]-angiotensin II.
    Abdulkader RC; Silva HB; Marcondes M; Vasconcelos EA; Paiva AC
    J Pharm Pharmacol; 1979 Jan; 31(1):20-2. PubMed ID: 32360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation constant of angiotensin II as determined by the use of an irreversible specific inhibitor (1-Sar-8-Leu-AT II ).
    Regoli D; Rioux F; Park WK
    Rev Can Biol; 1972 Mar; 31(1):73-7. PubMed ID: 4336058
    [No Abstract]   [Full Text] [Related]  

  • 37. II. Pharmacology of angiotensin antagonists.
    Regoli D; Park WK; Rioux F
    Can J Physiol Pharmacol; 1973 Feb; 51(2):114-21. PubMed ID: 4348959
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues.
    Regoli D; Rioux F; Park WK; Choi C
    Can J Physiol Pharmacol; 1974 Feb; 52(1):39-49. PubMed ID: 4363494
    [No Abstract]   [Full Text] [Related]  

  • 40. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.